Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Author:

Wong Edwin,Nester Carla,Cavero Teresa,Karras Alexandre,Le Quintrec Moglie,Lightstone Liz,Eisenberger Ute,Soler Maria Jose,Kavanagh David,Daina Erica,Praga Manuel,Medjeral-Thomas Nicholas R.,Gäckler Anja,Garcia-Carro Clara,Biondani Andrea,Chaperon Frederique,Kulmatycki Kenneth,Milojevic Julie,Webb Nicholas J.A.,Nidamarthy Prasanna Kumar,Junge Guido,Remuzzi Giuseppe

Funder

Novartis

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. Update on C3 glomerulopathy: a complement-mediated disease;Caravaca-Fontán;Nephron,2020

2. C3 glomerulopathy: understanding an ultra-rare complement-mediated renal disease;Heiderscheit;Am J Med Genet C Semin Med Genet,2022

3. Characterization of C3 in C3 glomerulopathy;Sethi;Nephrol Dial Transplant,2017

4. Diagnosis of complement alternative pathway disorders;Angioi;Kidney Int,2016

5. Mayo Clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN;Sethi;J Am Soc Nephrol,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. C3 Glomerulopathy: Novel Treatment Paradigms;Kidney International Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3